UPDATE: Leerink Partners Initiates Coverage On Five Prime Therapeutics On Multiple Value Drivers

By: via Benzinga
In a report published Friday, Leerink Partners analyst Michael Schmidt initiated coverage on Five Prime Therapeutics (NASDAQ: FPRX) with ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.